It is suggested that the mechanism of action through which probiotics prevent insulin resistance is via the inhibition of the β‐cell destruction in the islets of Langerhans, promoting the transcription of glucose transporter 4 (GLUT4) and extracellular signal‐regulated kinase 2 (ERK2) levels, as well as alleviating inflammation (Valenlia et al. 2018). The gene discussed is SLC2A4; the disease is Insulin resistance.